IP Library Granted Patent US 7,923,006
Granted Patent B2
US 7,923,006 · App. 11/875,441 · Granted Apr 12, 2011

Method for preventing or treating the development of respiratory allergies

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,923,006
App. No.
11/875,441
Granted
Apr 12, 2011
Kind
B2
Abstract

The present invention is directed to a novel method for preventing or treating the development of respiratory allergies. The method comprises prenatal and/or postnatal administration of a therapeutically effective amount of LGG.

Claims (11)

1. A method for preventing or reducing the production of serum IgE antibodies in an infant, the method comprising prenatally administering to the infant an effective amount of Lactobacillus rhamnosus GG prior to allergic sensitization of the infant.

2. The method of claim 1 , wherein the prenatal administration of Lactobacillus GG comprises ingestion of Lactobacillus GG by the pregnant mother of the unborn infant.

3. The method of claim 1 , wherein the amount of Lactobacillus GG administered to the infant is between about 1×10 4 and 1×10 12 cfu/L/kg/day.

4. The method of claim 1 , wherein the amount of Lactobacillus GG administered to the infant is between about 1×10 6 and 1×10 9 cfu/L/kg/day.

5. A method for preventing or reducing the production of serum IgE antibodies in an infant, the method comprising postnatally administering to the infant an effective amount of Lactobacillus rhamnosus GG prior to allergic sensitization of the infant.

6. The method of claim 5 , wherein the postnatal administration of Lactobacillus GG comprises ingestion of Lactobacillus GG by the infant's mother followed by breast feeding of the infant by the mother.

7. The method of claim 5 , wherein the postnatal administration of Lactobacillus GG comprises incorporation of the Lactobacillus GG into an infant formula and consumption of the formula by the infant.

8. The method of claim 5 , wherein the amount of Lactobacillus GG administered to the infant is between about 1×10 4 and 1×10 12 cfu/L/kg/day.

9. The method of claim 5 , wherein the amount of Lactobacillus GG administered to the infant is between about 1×10 6 and 1×10 9 cfu/L/kg/day.

10. The method of claim 5 , wherein the method further comprises administering to the infant at least one additional probiotic.

11. The method of claim 5 , wherein the method further comprises administering to the infant at least one prebiotic.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2009
From: HERZ, UDO
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 022561/0699 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2009
From: RENZ, HARALD; BLUEMER, NICOLE; GARN, HOLGER
To: PHILLIPS-UNIVERSITAET MARBURG
Reel/Frame 022561/0782 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2009
From: PHILLIPS-UNIVERSITAT MARBURG
To: TRANSMIT
Reel/Frame 022561/0816 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2009
From: TRANSMIT GESELLSCHAFT FUR TECHNOLOGIETRANSFER MBH
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 022561/0919 →
MERGER Recorded Mar 9, 2009
From: MJN RESTRUCTURING HOLDCO, INC.
To: MEAD JOHNSON NUTRITION COMPANY
Reel/Frame 022354/0768 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2009
From: BRISTOL-MYERS SQUIBB COMPANY
To: MJN RESTRUCTURING HOLDCO, INC.
Reel/Frame 022248/0663 →